In head-to-head comparison of plasma biomarkers in prodromal AD, p-tau217 had higher accuracy compared to other p-tau biomarkers when identifying patients with abnormal Aβ and tau status and those who are progressing to AD [30, 32]. Here, MAPT is linked to Alzheimer disease.